NeoNotes Home | Index | Search | Submit Article Summary | Email the Editor | FSN Home Page
| Ref # | Topic | Date Reviewed | Reviewer | Additional Comments |
|---|---|---|---|---|
| 2-057 | Dec 2001 | Andrew B. Kairalla MD | 0 | |
| 2-056 | Guidelines for Post-Natal Dexamethasone | Dec 2001 | Andrew B. Kairalla MD | 4 |
| 2-055 | Postnatal Steroids - the OSECT Study | Dec 2001 | Andrew B. Kairalla MD | 0 |
| 2-054 | Postnatal Steroids - Risks vs Benefits | Dec 2001 | Andrew B. Kairalla MD | 0 |
| 2-053 | Dec 2001 | Andrew B. Kairalla MD | 0 | |
| 2-052 | Dec 2001 | Andrew B. Kairalla MD | 0 | |
| 2-051 | Nov 2001 | Andrew B. Kairalla MD | 0 | |
| 2-050 | Nov 2001 | Andrew B. Kairalla MD | 0 | |
| 2-049 | Nov 2001 | Andrew B. Kairalla MD | 0 | |
| 2-048 | Nov 2001 | Andrew B. Kairalla MD | 0 | |
| 2-047 | Nov 2001 | Andrew B. Kairalla MD | 0 | |
| 2-046 | Capnography for ET Placement | Nov 2001 | Andrew B. Kairalla MD | 0 |
| 2-045 | End-Tidal Carbon Monoxide V | Oct 2001 | Andrew B. Kairalla MD | 0 |
| 2-044 | End-Tidal Carbon Monoxide IV | Oct 2001 | Andrew B. Kairalla MD | 0 |
| 2-043 | End-Tidal Carbon Monoxide III | Oct 2001 | Andrew B. Kairalla MD | 0 |
| 2-042 | End-Tidal Carbon Monoxide II | Oct 2001 | Andrew B. Kairalla MD | 0 |
| 2-041 | Oct 2001 | Andrew B. Kairalla MD | 0 | |
| 2-040 | Oct 2001 | Andrew B. Kairalla MD | 0 | |
| 2-039 | Oct 2001 | Andrew B. Kairalla MD | 0 | |
| 2-038 | Sep 2001 | Andrew B. Kairalla MD | 0 | |
| 2-037 | Sep 2001 | Andrew B. Kairalla MD | 0 | |
| 2-036 | Sep 2001 | Andrew B. Kairalla MD | 0 | |
| 2-035 | Sep 2001 | Andrew B. Kairalla MD | 1 | |
| 2-034 | Sep 2001 | Andrew B. Kairalla MD | 0 | |
| 2-033 | Aug 2001 | Andrew B. Kairalla MD | 0 | |
| 2-032 | Aug 2001 | Andrew B. Kairalla MD | 0 | |
| 2-031 | Aug 2001 | Andrew B. Kairalla MD | 0 | |
| 2-030 | Aug 2001 | Andrew B. Kairalla MD | 0 | |
| 2-029 | Aug 2001 | Andrew B. Kairalla MD | 0 | |
| 2-028 | July 2001 | Andrew B. Kairalla MD | 0 | |
| 2-027 | July 2001 | Andrew B. Kairalla MD | 0 | |
| 2-026 | July 2001 | Andrew B. Kairalla MD | 0 | |
| 2-025 | July 2001 | Andrew B. Kairalla MD | 0 | |
| 2-024 | June 2001 | Andrew B. Kairalla MD | 0 | |
| 2-023 | June 2001 | Andrew B. Kairalla MD | 0 | |
| 2-022 | June 2001 | Andrew B. Kairalla MD | 0 | |
| 2-021 | June 2001 | Andrew B. Kairalla MD | 0 | |
| 2-020 | May 2001 | Andrew B. Kairalla MD | 0 | |
| 2-019 | May 2001 | Andrew B. Kairalla MD | 0 | |
| 2-018 | May 2001 | Andrew B. Kairalla MD | 0 | |
| 2-017 | Apr 2001 | Andrew B. Kairalla MD | 1 | |
| 2-016 | Partial ETT Occlusion on HFOV | Apr 2001 | Andrew B. Kairalla MD | 0 |
| 2-015 | Exhaled CO2 Monitoring on HFOV | Apr 2001 | Andrew B. Kairalla MD | 0 |
| 2-014 | Apr 2001 | Andrew B. Kairalla MD | 0 | |
| 2-013 | Mar 2001 | Ernesto Valdes MD | 0 | |
| 2-012 | Feeding Hindmilk | Mar 2001 | Ernesto Valdes MD | 0 |
| 2-011 | Mar 2001 | Ernesto Valdes MD | 1 | |
| 2-010 | Mar 2001 | Ernesto Valdes MD | 0 | |
| 2-009 | Mar 2001 | Andrew B. Kairalla MD | 0 | |
| 2-008 | Mar 2001 | Andrew B. Kairalla MD | 0 | |
| 2-007 | Mar 2001 | Andrew B. Kairalla MD | 0 | |
| 2-006 | Mar 2001 | Andrew B. Kairalla MD | 0 | |
| 2-005 | Mar 2001 | Andrew B. Kairalla MD | 0 | |
| 2-004 | Cytokines for Sepsis II | Feb 2001 | Andrew B. Kairalla MD | 0 |
| 2-003 | Cytokines for Sepsis I | Feb 2001 | Andrew B. Kairalla MD | 0 |
| 2-002 | Fluconazole Prophylaxis | Feb 2001 | Andrew B. Kairalla MD | 0 |
| 2-001 | VLBW Outcomes | Feb 2001 | Andrew B. Kairalla MD | 0 |